Vimal K. Derebail

4.9k total citations
95 papers, 1.9k citations indexed

About

Vimal K. Derebail is a scholar working on Genetics, Hematology and Nephrology. According to data from OpenAlex, Vimal K. Derebail has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Genetics, 40 papers in Hematology and 27 papers in Nephrology. Recurrent topics in Vimal K. Derebail's work include Hemoglobinopathies and Related Disorders (40 papers), Iron Metabolism and Disorders (36 papers) and Renal Diseases and Glomerulopathies (24 papers). Vimal K. Derebail is often cited by papers focused on Hemoglobinopathies and Related Disorders (40 papers), Iron Metabolism and Disorders (36 papers) and Renal Diseases and Glomerulopathies (24 papers). Vimal K. Derebail collaborates with scholars based in United States, Canada and United Kingdom. Vimal K. Derebail's co-authors include Nigel S. Key, Kenneth I. Ataga, Patrick H. Nachman, Ronald J. Falk, Abhijit V. Kshirsagar, Susan L. Hogan, J. Charles Jennette, David R. Archer, Taewoo Lee and Rakhi P. Naik and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Vimal K. Derebail

84 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vimal K. Derebail United States	26	862	711	676	401	189	95	1.9k
Tom Cairns United Kingdom	26	353 0.4×	821 1.2×	376 0.6×	509 1.3×	506 2.7×	59	2.3k
Carlo Manno Italy	25	197 0.2×	1.3k 1.8×	365 0.5×	417 1.0×	443 2.3×	62	2.4k
Fabrizio Fabris Italy	25	578 0.7×	182 0.3×	1.1k 1.6×	146 0.4×	242 1.3×	102	2.0k
Damien Noone Canada	20	167 0.2×	849 1.2×	168 0.2×	260 0.6×	149 0.8×	70	1.4k
Eduardo Gutiérrez Spain	24	145 0.2×	1.2k 1.6×	361 0.5×	274 0.7×	86 0.5×	86	1.9k
Gastón Zilleruelo United States	26	241 0.3×	1.0k 1.5×	237 0.4×	386 1.0×	269 1.4×	76	2.1k
Simeone Andrulli Italy	29	177 0.2×	2.1k 2.9×	572 0.8×	852 2.1×	202 1.1×	77	2.9k
Sameena Iqbal United Kingdom	24	629 0.7×	252 0.4×	270 0.4×	224 0.6×	83 0.4×	65	2.0k
Rachael F. Grace United States	22	471 0.5×	126 0.2×	1.7k 2.5×	321 0.8×	38 0.2×	109	2.3k
William L. Nichols United States	29	406 0.5×	113 0.2×	1.8k 2.6×	211 0.5×	277 1.5×	67	2.5k

Countries citing papers authored by Vimal K. Derebail

Since Specialization

Citations

This map shows the geographic impact of Vimal K. Derebail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vimal K. Derebail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vimal K. Derebail more than expected).

Fields of papers citing papers by Vimal K. Derebail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vimal K. Derebail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vimal K. Derebail. The network helps show where Vimal K. Derebail may publish in the future.

Co-authorship network of co-authors of Vimal K. Derebail

This figure shows the co-authorship network connecting the top 25 collaborators of Vimal K. Derebail. A scholar is included among the top collaborators of Vimal K. Derebail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vimal K. Derebail. Vimal K. Derebail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grover, Steven P., Chatphatai Moonla, Michael W. Henderson, et al.. (2025). Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model. Blood Advances. 9(11). 2709–2721. 1 indexed citations

Xi, Gang, Olivier M. Lardinois, Peiqi Hu, et al.. (2025). Sequential carbonyl derivatives and hydrazone adduct formation on myeloperoxidase contribute to development of ANCA vasculitis. Journal of Clinical Investigation. 135(8). 2 indexed citations

Helmuth, Margaret, Salem Almaani, Isabelle Ayoub, et al.. (2025). Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN). Kidney International Reports. 10(6). 1917–1928. 1 indexed citations

Derebail, Vimal K., Payal Desai, Laila Elsherif, et al.. (2024). Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study. British Journal of Haematology. 205(3). 1159–1169. 1 indexed citations

Massicotte‐Azarniouch, David, Mark Canney, Peter A. Merkel, et al.. (2024). Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians. Kidney Medicine. 6(8). 100858–100858. 2 indexed citations

Beaudoin, James J., Vimal K. Derebail, William A. Murphy, et al.. (2024). Altered bile acid and coproporphyrin‐I disposition in patients with autosomal dominant polycystic kidney disease. British Journal of Clinical Pharmacology. 91(2). 353–364. 1 indexed citations

Hogan, Susan L., et al.. (2023). Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis. Journal of Managed Care & Specialty Pharmacy. 29(7). 770–781. 1 indexed citations

Kucirka, Lauren M., Ana M. Angarita, Tracy A. Manuck, et al.. (2023). Characteristics and Outcomes of Patients With Pregnancy-Related End-Stage Kidney Disease. JAMA Network Open. 6(12). e2346314–e2346314. 2 indexed citations

Wang, Linda, Dorey A. Glenn, Katherine R. Tuttle, et al.. (2023). Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrology. 24(1). 30–30. 4 indexed citations

10.

Wilson, Samuel, et al.. (2023). Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations. Kidney360. 4(7). 997–1005. 1 indexed citations

11.

Googe, Paul B., Vimal K. Derebail, Manish K. Saha, et al.. (2023). Cutaneous Acanthamoeba Infection Presenting with Granulomatous Vasculitis. SKIN The Journal of Cutaneous Medicine. 7(2). 700–704. 2 indexed citations

12.

Li, Xintong, et al.. (2022). Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries. Journal of Managed Care & Specialty Pharmacy. 28(11). 1292–1303. 3 indexed citations

13.

Skinner, Sarah, Vimal K. Derebail, Caroline J. Poulton, et al.. (2021). Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review. Kidney Medicine. 3(4). 607–618. 24 indexed citations

14.

Brady, Tammy M., Kevin Meyers, Michelle M. O’Shaughnessy, et al.. (2021). Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies. The Nephron journals/Nephron journals. 145(3). 245–255. 11 indexed citations

15.

Saraf, Santosh L., Kenneth I. Ataga, Vimal K. Derebail, et al.. (2021). A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST). Blood. 138(Supplement 1). 3096–3096. 6 indexed citations

16.

Derebail, Vimal K., Qingning Zhou, Emily J. Ciccone, Jianwen Cai, & Kenneth I. Ataga. (2021). Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease. British Journal of Haematology. 195(1). 123–132. 9 indexed citations

17.

Trachtman, Howard, Peter J. Nelson, Sharon G. Adler, et al.. (2018). DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. Journal of the American Society of Nephrology. 29(11). 2745–2754. 129 indexed citations

18.

Derebail, Vimal K., Abhijit V. Kshirsagar, Nigel S. Key, et al.. (2014). Sickle Trait in African-American Hemodialysis Patients and Higher Erythropoiesis-Stimulating Agent Dose. Journal of the American Society of Nephrology. 25(4). 819–826. 13 indexed citations

19.

Liapis, George, Harsharan K. Singh, Vimal K. Derebail, et al.. (2012). Diagnostic Significance of Peritubular Capillary Basement Membrane Multilaminations in Kidney Allografts. Transplantation. 94(6). 620–629. 29 indexed citations

20.

Hicks, Andrew A., Carl D. Langefeld, Lingyi Lu, et al.. (2011). Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney International. 80(12). 1339–1343. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact